• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项基于人群的新诊断卵巢癌女性肝转移研究。

A Population-Based Study on Liver Metastases in Women With Newly Diagnosed Ovarian Cancer.

作者信息

Zhao Haiyun, Xu Fei, Li Jiajia, Ni Mengdong, Wu Xiaohua

机构信息

Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.

Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.

出版信息

Front Oncol. 2020 Sep 25;10:571671. doi: 10.3389/fonc.2020.571671. eCollection 2020.

DOI:10.3389/fonc.2020.571671
PMID:33102229
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7545579/
Abstract

The purpose of this study was to analyze the incidence, clinical characteristics, prognostic factors and survival of ovarian cancer patients with liver metastases upon initial diagnosis. Patients with ovarian cancer liver metastases upon initial diagnosis between 2010 and 2016 were identified from the Surveillance, Epidemiology, and End Results (SEER) database. Univariate and multivariate logistic regression was performed to identify the predictors of the presence of liver metastases in newly diagnosed ovarian cancer patients. Overall survival (OS) was assessed using the Kaplan-Meier method and log-rank test. Univariate and multivariate Cox regression was conducted to determine the independent prognostic factors for OS. A total of 1,744 ovarian cancer patients with liver metastases was identified from the SEER database, accounting for 6.7% of the entire ovarian cancer patients. As to the unique distant organ provided by SEER, liver was the most common metastatic site of ovarian cancer (4.65%). Age, race, laterality, histology, pathological grade, extrahepatic sites, stage of tumor were the predictors of the presence with liver metastases revealed by multivariable logistic regression model. Median OS for the patients with liver metastases at initial diagnosis of ovarian cancer was 16.0 months. Multivariate Cox regression model confirmed race, histology, extrahepatic metastatic sites, surgery and marital status were independent prognostic factors for OS. The study provided population-based estimates of the incidence and prognosis of newly diagnosed ovary cancer patients with liver metastases, which could be potentially used for the risk assessment and individualized treatment.

摘要

本研究的目的是分析初诊时伴有肝转移的卵巢癌患者的发病率、临床特征、预后因素及生存率。从监测、流行病学和最终结果(SEER)数据库中识别出2010年至2016年初诊时伴有卵巢癌肝转移的患者。进行单因素和多因素逻辑回归分析,以确定新诊断卵巢癌患者肝转移的预测因素。采用Kaplan-Meier法和对数秩检验评估总生存期(OS)。进行单因素和多因素Cox回归分析,以确定OS的独立预后因素。从SEER数据库中识别出1744例伴有肝转移的卵巢癌患者,占整个卵巢癌患者的6.7%。就SEER提供的唯一远处器官而言,肝脏是卵巢癌最常见的转移部位(4.65%)。年龄、种族、肿瘤侧别、组织学类型、病理分级、肝外转移部位、肿瘤分期是多因素逻辑回归模型显示的肝转移存在的预测因素。初诊时伴有肝转移的卵巢癌患者的中位OS为16.0个月。多因素Cox回归模型证实种族、组织学类型、肝外转移部位、手术和婚姻状况是OS的独立预后因素。本研究提供了基于人群的初诊时伴有肝转移的卵巢癌患者的发病率和预后估计,这可能潜在地用于风险评估和个体化治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/473d/7545579/94368310c494/fonc-10-571671-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/473d/7545579/a06d05686126/fonc-10-571671-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/473d/7545579/94368310c494/fonc-10-571671-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/473d/7545579/a06d05686126/fonc-10-571671-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/473d/7545579/94368310c494/fonc-10-571671-g0002.jpg

相似文献

1
A Population-Based Study on Liver Metastases in Women With Newly Diagnosed Ovarian Cancer.一项基于人群的新诊断卵巢癌女性肝转移研究。
Front Oncol. 2020 Sep 25;10:571671. doi: 10.3389/fonc.2020.571671. eCollection 2020.
2
Incidence proportions and prognosis of breast cancer patients with bone metastases at initial diagnosis.初诊时发生骨转移的乳腺癌患者的发病比例和预后。
Cancer Med. 2018 Aug;7(8):4156-4169. doi: 10.1002/cam4.1668. Epub 2018 Jul 9.
3
Liver Metastases in Newly Diagnosed Gastric Cancer: A Population-Based Study from SEER.新诊断胃癌的肝转移:一项基于监测、流行病学和最终结果(SEER)数据库的人群研究
J Cancer. 2019 Jun 2;10(13):2991-3005. doi: 10.7150/jca.30821. eCollection 2019.
4
Frequency and Prognosis of Pulmonary Metastases in Newly Diagnosed Gastric Cancer.新诊断胃癌肺转移的发生率及预后
Front Oncol. 2019 Jul 30;9:671. doi: 10.3389/fonc.2019.00671. eCollection 2019.
5
The Prevalence and associated Factors for Liver Metastases, Development and Prognosis in newly diagnosed Epithelial Ovarian Cancer: A large Population-Based Study from the SEER Database.新诊断上皮性卵巢癌肝转移的患病率、相关因素、发展及预后:一项基于监测、流行病学和最终结果(SEER)数据库的大型人群研究
J Cancer. 2020 Jun 8;11(16):4861-4869. doi: 10.7150/jca.40590. eCollection 2020.
6
Prognostic Factors among Brain Metastases in Newly Diagnosed Ovary Cancer: A Large Real-world Study.新诊断卵巢癌脑转移的预后因素:一项大型真实世界研究
J Cancer. 2020 May 18;11(15):4625-4640. doi: 10.7150/jca.44494. eCollection 2020.
7
A Population-Based Study on Liver Metastases in Women with Newly Diagnosed Breast Cancer.基于人群的女性新发乳腺癌肝转移研究。
Cancer Epidemiol Biomarkers Prev. 2019 Feb;28(2):283-292. doi: 10.1158/1055-9965.EPI-18-0591. Epub 2018 Nov 28.
8
Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.胰腺腺癌中特定部位转移的预后价值:一项监测、流行病学和最终结果数据库分析。
World J Gastroenterol. 2017 Mar 14;23(10):1872-1880. doi: 10.3748/wjg.v23.i10.1872.
9
Incidence and prognostic factors of patients with synchronous liver metastases upon initial diagnosis of breast cancer: a population-based study.乳腺癌初诊时伴有同时性肝转移患者的发病率及预后因素:一项基于人群的研究
Cancer Manag Res. 2018 Nov 20;10:5937-5950. doi: 10.2147/CMAR.S178395. eCollection 2018.
10
Clinical Characteristics and Prognostic Factors of Endometrial Cancer Patients With Liver Metastasis: A Surveillance, Epidemiology, and End Results Database (SEER)-Based Study of 1,034 Women.子宫内膜癌肝转移患者的临床特征及预后因素:一项基于监测、流行病学和最终结果数据库(SEER)的1034例女性研究
Cureus. 2024 Feb 21;16(2):e54606. doi: 10.7759/cureus.54606. eCollection 2024 Feb.

引用本文的文献

1
Effect of different treatment modalities on ovarian cancer patients with liver metastases: A retrospective cohort study based on SEER.不同治疗方式对卵巢癌伴肝转移患者的影响:一项基于 SEER 的回顾性队列研究。
PLoS One. 2024 Apr 18;19(4):e0299504. doi: 10.1371/journal.pone.0299504. eCollection 2024.
2
The Importance of Marital Status in the Morbidity and Prognosis of Lung Metastasis in Newly Diagnosed Ovarian Cancer.婚姻状况对新诊断卵巢癌肺转移发病率及预后的重要性
J Cancer. 2023 Apr 9;14(6):1024-1038. doi: 10.7150/jca.83017. eCollection 2023.
3
Nomogram Models for Predicting Risk and Prognosis of Newly Diagnosed Ovarian Cancer Patients with Liver Metastases - A Large Population-Based Real-World Study.

本文引用的文献

1
Percutaneous microwave ablation versus surgical resection for ovarian cancer liver metastasis.经皮微波消融与手术切除治疗卵巢癌肝转移的比较。
Int J Hyperthermia. 2020;37(1):28-36. doi: 10.1080/02656736.2019.1706767.
2
Ovarian, uterine, and cervical cancer patients with distant metastases at diagnosis: most common locations and outcomes.诊断时患有远处转移的卵巢癌、宫颈癌和子宫体癌患者:最常见的转移部位和结局。
Clin Exp Metastasis. 2020 Feb;37(1):107-113. doi: 10.1007/s10585-019-10007-0. Epub 2019 Nov 22.
3
Prognostic factors value of germline and somatic brca in patients undergoing surgery for recurrent ovarian cancer with liver metastases.
预测新诊断的伴有肝转移的卵巢癌患者风险和预后的列线图模型——一项基于大人群的真实世界研究
J Cancer. 2021 Oct 25;12(24):7255-7265. doi: 10.7150/jca.64255. eCollection 2021.
胚系和体细胞 BRCA 对接受手术治疗复发性卵巢癌伴肝转移患者的预后因素价值。
Eur J Surg Oncol. 2019 Nov;45(11):2096-2102. doi: 10.1016/j.ejso.2019.06.023. Epub 2019 Jun 13.
4
CD44 Regulates Formation of Spheroids and Controls Organ-Specific Metastatic Colonization in Epithelial Ovarian Carcinoma.CD44 调节球体的形成,并控制上皮性卵巢癌的器官特异性转移定植。
Mol Cancer Res. 2019 Sep;17(9):1801-1814. doi: 10.1158/1541-7786.MCR-18-1205. Epub 2019 May 30.
5
Surgical treatment of ovarian cancer liver metastasis.卵巢癌肝转移的外科治疗
Hepatobiliary Surg Nutr. 2019 Apr;8(2):129-137. doi: 10.21037/hbsn.2018.12.06.
6
Cancer statistics, 2019.癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
7
Molecular Mechanisms Regulating Organ-Specific Metastases in Epithelial Ovarian Carcinoma.调控上皮性卵巢癌器官特异性转移的分子机制
Cancers (Basel). 2018 Nov 15;10(11):444. doi: 10.3390/cancers10110444.
8
miR-203 inhibits ovarian tumor metastasis by targeting BIRC5 and attenuating the TGFβ pathway.miR-203 通过靶向 BIRC5 并抑制 TGFβ 通路抑制卵巢肿瘤转移。
J Exp Clin Cancer Res. 2018 Sep 21;37(1):235. doi: 10.1186/s13046-018-0906-0.
9
Sites of distant metastases and overall survival in ovarian cancer: A study of 1481 patients.卵巢癌远处转移部位与总生存期:一项 1481 例患者的研究。
Gynecol Oncol. 2018 Sep;150(3):460-465. doi: 10.1016/j.ygyno.2018.06.022. Epub 2018 Jul 9.
10
Upregulation of IGF1 by tumor-associated macrophages promotes the proliferation and migration of epithelial ovarian cancer cells.肿瘤相关巨噬细胞上调 IGF1 促进上皮性卵巢癌细胞的增殖和迁移。
Oncol Rep. 2018 Feb;39(2):818-826. doi: 10.3892/or.2017.6148. Epub 2017 Dec 11.